Hannu Paajanen
Kuopio, 70600, Finland
NCT Number: NCT01295437
Chronic pain may be a long-term problem after inguinal Lichtenstein hernioplasty. The aim of this study was to compare long-term results of hernioplasty using three different meshes (partly absorbable, lightweight polypropylene and thick polypropylene mesh).
Looking for future studies?
Notify Me18 year–85 year
All sexes
Interventional
Not applicable
Kuopio, 70600, Finland
Inguinal hernioplasty was performed under local anesthesia in 300 patients in day-case surgery by the same surgeon and exactly by the same surgical technique. The patients were randomized to receive either a partly polypropylene-polyglactin mesh (Vypro II, 100 hernias), a lightweight polypropylene mesh (Premilene LP, 100 hernias) or a conventional densely woven polypropylene mesh (Premilene, 100 hernias). Pain, patients discomfort and recurrences of hernias were carefully followed 5 years after surgery.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
partly absorbable mesh
Other names: polypropylene-polyglactin mesh
lightweight mesh
Other names: lightweight polypropylene
A conventional polypropylene mesh (82 g/m2)
Other names: polypropylene mesh
Time frame: 5 years
Pain scores were measured by using a visual analoque scale.
Time frame: 5 years
Recurrence of inguinal hernias after Lichtenstein hernioplasty was studies during clinical and ultrasound examination
Kuopio University Hospital
Other
A Single-surgeon Randomized Study Comparing Three Composite Meshes on Chronic Pain After Lichtenstein Hernia Repair in Local Anesthesia
Acronym: Lichtenstein
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06314152
Chronic Pain, Disease Attributes
Nanchong, Sichuan, China
View Trial DetailsNCT05929378
Chronic Pain, Disease Attributes
Nanchong, Sichuan, China
View Trial DetailsNCT01597011
Chronic Pain, Disease Attributes
Herlev, Denmark
View Trial DetailsNCT01070693
Chronic Pain, Disease Attributes
Espoo, Finland
View Trial Details